Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul;24(9):1215-1226.
doi: 10.1177/1087054715569280. Epub 2015 Feb 5.

Treatments for Adolescents With Comorbid ADHD and Substance Use Disorder: A Systematic Review

Michelle J Zaso  1 , Aesoon Park  1 , Kevin M Antshel  1
Affiliations

Treatments for Adolescents With Comorbid ADHD and Substance Use Disorder: A Systematic Review

Michelle J Zaso et al. J Atten Disord. 2020 Jul.

Abstract

Objective: Comorbid ADHD and substance use disorder (SUD) presents frequently in adolescence, a developmental period that may promote the emergence of substance misuse among individuals with ADHD. Comorbid ADHD and SUD in adolescence results in significant and unique treatment challenges, necessitating examination into effective interventions. Method: This systematic review examined existing research into the treatment of comorbid adolescent ADHD and SUD. Results: Findings from a small number of pharmacological intervention studies suggest potential efficacy of extended-release stimulant and nonstimulant medications. Efficacy of psychotherapeutic interventions has not been systematically examined. Conclusion: Current research on treatments for comorbid ADHD and SUD in adolescence is limited. Future placebo-controlled clinical trials using large samples are needed to examine the efficacy of psychotherapeutic interventions, the heightened risk of prescription stimulant misuse, and the long-term maintenance of treatment gains in this population. Clinical guidelines for the treatment of comorbid ADHD and SUD are discussed.

Keywords: ADHD; adolescents; substance-related disorders; treatment.

PubMed Disclaimer

References

    1. Adler LA, Guida F, Irons S, Shaw DM. Open label pilot study of atomoxetine in adults with ADHD and substance use disorder. Journal of Dual Diagnosis. 2010;6:3–4. 196–207. doi: 10.1080/15504263.2010.537224. - DOI
    1. Antshel KM, Faraone SV, Gordon M. Cognitive behavioral treatment outcomes in adolescent ADHD. Journal of Attention Disorders. 2012;18(6):483–495. doi: 10.1177/1087054712443155. - DOI - PubMed
    1. Baer JS, Peterson PL. Motivational intervieweing with adolescents and young adults. In: Miller WR, Rollnick S, editors. Motivational Intervieweing: Preparing People for Change. 2. New York: Guilford Press; 2002. pp. 320–332.
    1. Barkley RA, Murphy KR, Fischer M. ADHD in Adults: What the Science Says. New York, NY: Guilford; 2008. Comorbid psychiatric disorders and psychological maladjustment; pp. 205–244.
    1. Barnett E, Sussman S, Smith C, Rohrbach LA, Spruijt-Metz D. Motivational Interviewing for adolescent substance use: A review of the literature. Addictive Behaviors. 2012;37(12):1325–1334. doi: 10.1016/j.addbeh.2012.07.001. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances